Alimera Sciences (ALIM) Files $75M IPO

July 1, 2008 5:33 PM EDT
Get Alerts ALIM Hot Sheet
Price: $4.63 +0.65%

Overall Analyst Rating:
    BUY (= Flat)

Trade Now! 
Join SI Premium – FREE
Alimera Sciences (Nasdaq: ALIM) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $75 million. The company plans to list on the NASDAQ under the stock symbol "ALIM."

The offering is being made through Credit Suisse, Citi, Cowen and Company and Leerink Swann.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

You May Also Be Interested In

Related Categories


Related Entities

Credit Suisse, Citi